About 3 results found for searched term "Cantuzumab" (0.127 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M25224 | Cantuzumab mertansine | Drug-Linker Conjugates for ADC |
| SB-408075; huC242-DM1 | ||
| Cantuzumab mertansine (SB-408075; huC242-DM1), an ADC, is an immunoconjugate of the potent maytansine derivative and the humanized monoclonal antibody (huC242) directed to CanAg. Cantuzumab mertansine has cytotoxic toward colon cancer cells and has broad antitumor efficacy against a range of CanAg-positive human tumor xenografts. | ||
| M25258 | Cantuzumab ravtansine | Drug-Linker Conjugates for ADC |
| IMGN242; huC242-DM4 | ||
| Cantuzumab ravtansine (IMGN242; huC242-DM4), an ADC, is a humanized monoclonal antibody huC242 covalently linked via a disulfide bond to DM4. Cantuzumab ravtansine has broad antitumor efficacy against a range of CanAg-positive human tumor xenografts. | ||
| M55641 | Cantuzumab | Others |
| Cantuzumab is a monoclonal antibody that can binds the CanAg antigen. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
